Daewoong Co., Ltd. Profile Avatar - Palmy Investing

Daewoong Co., Ltd.

Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd.

Drug Manufacturers - General
KR, Hwaseong-si [HQ]

Cash Flow Statements

15 Records · Starting from 2009
In Million KRW. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
118,036.00 34,417.00 10,404.00 27,615.00 86,193.00 46,607.00 74,916.00 18,755.00 147,774.00 45,380.00 138,512.00 145,365.00 133,175.00 149,081.00 200,654.00
Operating Cash (Net)
118,036.00 34,417.00 10,404.00 27,615.00 86,193.00 46,607.00 74,916.00 18,755.00 147,774.00 45,380.00 138,512.00 145,365.00 133,175.00 149,081.00 200,654.00
Accounts Receivable
- - - - - - - - - - - - -12,730.00 -10,151.00 -5,027.00 -13,598.00 -25,766.00 45,492.00 -30,177.00 -36,658.00 -6,245.00
Accounts Payable
- - - - - - - - - - - - 5,917.00 13,708.00 -11,826.00 2,963.00 17,146.00 -3,441.00 2,397.00 6,555.00 13,625.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-86,444.00 -4,529.00 -32,516.00 6,880.00 -81,352.00 -166,213.00 -117,528.00 -181,849.00 -82,528.00 -79,153.00 -149,981.00 -30,786.00 -219,131.00 -105,493.00 -214,457.00
Capital Expenditure
-41,762.00 -74,842.00 -32,097.00 -8,394.00 -25,862.00 -61,305.00 -120,415.00 -174,038.00 -103,056.00 -67,076.00 -68,370.00 -65,084.00 -115,508.00 -117,622.00 -228,956.00
Purchases of Investments
-143,783.00 -11,068.00 -6,236.00 -4,939.00 -57,907.00 -151,996.00 -103,587.00 -130,840.00 -86,897.00 -254,375.00 -280,874.00 -502,035.00 -414,743.00 -72,116.00 -42,220.00
Sale/Maturity of Investment
73,408.00 88,919.00 4,771.00 5,268.00 8,741.00 44,859.00 110,349.00 119,871.00 116,043.00 246,491.00 212,362.00 442,215.00 308,355.00 85,297.00 71,686.00
Property, Plant, Equipment (P&PE)
-41,762.00 -74,842.00 -32,097.00 -8,394.00 -25,862.00 -61,305.00 -120,415.00 -174,038.00 -103,056.00 -67,076.00 -68,370.00 -65,084.00 -115,508.00 -117,622.00 -228,956.00
Acquisitions (Net)
-430.00 -673.00 5.00 8,344.00 -6,640.00 -4,375.00 -6,416.00 370.00 -10,547.00 -6,833.00 -1,125.00 -863.00 -564.00 553.00 -15,650.00
Other Investing Activities
22,570.00 -6,865.00 1,041.00 6,601.00 315.00 6,604.00 2,542.00 2,788.00 1,929.00 2,640.00 -11,973.00 94,982.00 3,329.00 -1,604.00 683.00
Financing Activities
Used Cash (Net)
-29,075.00 -6,649.00 -24,238.00 -15,402.00 -9,013.00 -92,772.00 -63,059.00 -168,744.00 -34,846.00 -6,389.00 -16,479.00 -16,270.00 -10,997.00 -22,571.00 -19,341.00
Debt Repayment
-33,000.00 - - -24,046.00 -59,243.00 -41,407.00 -34,808.00 -78,595.00 -115,219.00 -205,151.00 -99,157.00 -202,564.00 -94,357.00 -144,333.00 -201,211.00 -2,351.00
Dividends Paid
-7,907.00 -8,644.00 -3,435.00 -4,651.00 -8,984.00 -8,741.00 -8,181.00 -8,181.00 -7,678.00 - - -4,318.00 -4,318.00 -4,246.00 -4,156.00 -4,157.00
Common Stock
- - - - - - - - -53,100 - - - - - - - - 1 202,436 20,176 -143,232 429 10,085
Other Financing Activities
-6,168.00 15,294.00 51,721.00 48,492.00 1,392.00 136,322.00 149,836.00 292,145.00 177,983.00 100,448.00 -8,666.00 138,311.00 18,980.00 232,514.00 -2,924.00
Cash Balances
Begin of Period
54,718.00 56,657.00 20,840.00 22,978.00 92,549.00 106,261.00 79,409.00 100,994.00 106,208.00 135,155.00 95,125.00 67,456.00 196,872.00 124,629.00 190,435.00
End of Period
56,657.00 93,194.00 22,978.00 41,991.00 106,261.00 79,409.00 100,994.00 106,208.00 135,155.00 95,125.00 67,456.00 196,872.00 124,629.00 190,435.00 161,685.00
Change
1,939.00 36,536.00 2,137.00 19,013.00 13,712.00 -26,851.00 21,584.00 5,214.00 28,946.00 -40,030.00 -27,668.00 129,415.00 -72,242.00 65,805.00 -28,749.00
Non-Cash Balances
Depreciation and Amortization
19,021.00 15,712.00 10,474.00 12,734.00 30,252.00 30,143.00 36,760.00 38,785.00 50,216.00 59,061.00 49,881.00 50,848.00 50,557.00 48,279.00 52,563.00
Stock Based Compensation
- - - - - - - - - - - - 88.00 193.00 29.00 - - 1,034.00 1,268.00 2,159.00 1,984.00 1,755.00
Other
-5,118.00 10,498.00 -16,598.00 -10,899.00 32,667.00 18,777.00 -1,082.00 258.00 4,575.00 58,522.00 14,997.00 5,666.00 2,207.00 14,692.00 113,181.00
Highlighted metrics
Free Cash Flow (FCF)
76,273.00 -40,425.00 -21,693.00 19,220.00 60,331.00 -14,698.00 -45,499.00 -155,283.00 44,718.00 -21,695.00 70,141.00 80,281.00 17,666.00 31,458.00 -28,302.00
Cash Conversion Cycle (CCC)
91.00 18.00 75.00 85.00 132.00 129.00 141.00 170.00 178.00 182.00 147.00 142.00 131.00 157.00 147.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of 003090.KS's Analysis
CIK: - CUSIP: - ISIN: KR7003090008 LEI: - UEI: -
Secondary Listings
003090.KS has no secondary listings inside our databases.